Skip to main content

Prosthetic Heart Valves - Tissue Valves News

Updated Guidelines Issued for Assessing Prosthetic Heart Valves

TUESDAY, Jan. 16, 2024 – In guidelines issued by the American Society of Echocardiography and published online in the January issue of the Journal of the American Society of Echocardiography,...

Warfarin Cuts Mortality, Thromboembolism After Valve Replacement

THURSDAY, Jan. 4, 2024 – Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with...

Most Who Get Heart Valve Replacement Don't Get Follow-Up Rehab

TUESDAY, Oct. 10, 2023 – A majority of people who have a minimally invasive heart valve replacement procedure are not getting the recommended cardiac rehab after their surgeries, researchers say. A...

FDA Medwatch Alert: Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves

ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

warfarin, Coumadin